Support for Ukrainian pharma disclosing transfers of value to health care professionals and organizations in 2015

20 June 2016

The Ukraine Association of Pharmaceutical Research and Development (APRaD) has called its disclosure of information on transfers of value to health care professionals and organizations made in the country’s pharma industry in 2015 a step forward for transparency.

APRaD, which is disclosing the information this month, also believes this adoption of a European standard will help companies involved in Ukraine’s pharma industry to collaborate more closely with the medical community.

Internationally, the idea of open financial relationships between pharmaceutical companies and health care professionals is not new. In the USA, it was implemented at the legislative level in so-called Physician Payments Sunshine Act at the beginning of 2000s.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK